GEODE CAPITAL MANAGEMENT, LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,986,519
-$123,672 QoQ
Shares Held
2,523,114
+2.5% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. LCTX ranks #228 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,986,519 | 2,523,114 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,110,191 | 2,461,193 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,089,403 | 2,419,766 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,212,772 | 2,431,619 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,018,513 | 4,485,586 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,845,243 | 3,690,486 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,348,144 | 3,679,280 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,596,006 | 3,596,006 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,814,522 | 3,253,056 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,200,033 | 2,935,811 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,264,985 | 2,766,937 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,413,339 | 2,420,808 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,923,000 | 1,282,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,479,358 | 1,264,409 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,413,806 | 1,251,156 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,974,007 | 1,249,372 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,504,998 | 2,275,973 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,708,869 | 2,330,151 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,900,615 | 2,341,514 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,664,964 | 2,338,584 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,974,984 | 1,265,951 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,874,908 | 1,065,289 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $960,251 | 1,021,544 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $888,743 | 1,021,544 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,392,340 | 1,677,519 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||